Page last updated: 2024-08-21

oxazoles and Atrial Fibrillation

oxazoles has been researched along with Atrial Fibrillation in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dong, JM; Dong, ZX; Hang, PZ; Hou, TT; Li, WM; Li, Y; Liu, GZ; Liu, Y; Liu, YW; Shi, H; Sun, L; Wang, XB; Yuan, Y; Zhan, CC; Zhao, GQ; Zhao, J; Zhao, JJ; Zhou, JH	1
Imaizumi, S; Miura, S; Saku, K; Uehara, Y; Yahiro, E	1

Reviews

1 review(s) available for oxazoles and Atrial Fibrillation

Article	Year
Chymase inhibitors. Current pharmaceutical design, 2013, Volume: 19, Issue:17 Topics: Acetamides; Animals; Atrial Fibrillation; Azetidines; Benzoates; Cardiovascular Diseases; Chymases; Heart Failure; Humans; Hypertension; Mast Cells; Oxazoles; Pyrimidines; Quinazolines; Sulfonamides	2013

Other Studies

1 other study(ies) available for oxazoles and Atrial Fibrillation

Article	Year
Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway. British journal of pharmacology, 2016, Volume: 173, Issue:6 Topics: Animals; Atrial Fibrillation; Atrial Remodeling; Carbazoles; Cell Line; Fenofibrate; Heart Atria; Humans; Male; Middle Aged; Oxazoles; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR alpha; Rabbits; Sirtuin 1; Tyrosine	2016

Article

Year

Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway.

British journal of pharmacology, 2016, Volume: 173, Issue:6

Topics: Animals; Atrial Fibrillation; Atrial Remodeling; Carbazoles; Cell Line; Fenofibrate; Heart Atria; Humans; Male; Middle Aged; Oxazoles; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR alpha; Rabbits; Sirtuin 1; Tyrosine

2016